kneat.com, inc.

WHO'M

Digital Profiler. Simply click the AI button

CUSIP

498824101

SEDOL

N/A

CIK

N/A

www.kneat.com

LEI:

FIGI: BBG0063HM1D4

KSI

kneat.com, inc.

GICS: - · Sector: - · Sub-Sector: Health Information Services

PROFILER

NAME

kneat.com, inc.

ISIN

CA4988241010

TICKER

KSI

MIC

XTSE

REUTERS

KSI.TO

BLOOMBERG

KSI CN

BUILD THEMEFOLIO SHARE IDEAS DISCUSS

LEVERAGE INVEST

Financial Intelligence

360°^iHub Crowd^iFeed ATH Tracker Index Tracker ETF TF Spicy² X-Billboard

FOR INVESTORS

FOR TRADERS

Securities Trading Warrants

GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.

Tue, 17.12.2024

Medical devices and healthcare therapies maker signs 3-year Master Services Agreement with Kneat to streamline its computer systems validation processes.

Research & Analysis

Wed, 27.11.2024

ALTEN selects Kneat to digitize validation for itself and its customers.

Research & Analysis

Wed, 06.11.2024

Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively,

Research & Analysis

Thu, 31.10.2024

Kneat signs a global and diverse medical devices manufacturer for digital validation.

Research & Analysis

Wed, 30.10.2024

Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024, and Host an Earnings Call on November 7

Research & Analysis

Thu, 10.10.2024

Kneat closed its previously announced bought deal, issuing 7,500,000 shares for gross proceeds to the Company of $35.6 million.

Research & Analysis

Tue, 08.10.2024

Another global pharmaceutical company selects Kneat to digitize its validation processes.

Research & Analysis

Mon, 07.10.2024

Kneat filed a final short-form prospectus, which qualifies the distribution of common shares in connection with its previously announced bought deal.

Research & Analysis

Tue, 06.08.2024

Kneat's Q2 2024 Growth Accelerates YoY, with Revenue up 45%, Annual Recurring Revenue up 60%, Gross Profit up 63%

Research & Analysis

Wed, 29.05.2024

Kneat announces voting results of 2024 Annual General Meeting of shareholders.

Research & Analysis

We are different

OPEN FINANCIAL

DATA & KNOWLEDGE HUB

We make the difference

Information on product placements

Legend

SMART * AD

P R O D U C T S U G G E S T I O N S

First Name *

Last Name

Email *

Subject *

i.e Feature x is not working

Issue happened on *

This page

Other page

Bug Detail *

Please give us more detailed explanation of the issue

Steps to reproduce *

Specify the steps you've done before the issue happen

Actual Result *

What's the result of the issue?

Expected Result *

What do you expect to see?

Attachment

(Optional) You can send us a screenshot, word document, or a PDF explaining the issue

Please log in to your user account. This will allow us to contact you in case of any queries.

I would like to remain anonymous.

kneat.com, inc.

Global Medical Device Manufacturer Selects Kneat to Digitize Computer System Validation

ALTEN Selects Kneat to Digitize Validation

Kneat Achieves Record Results in Growth and Profitability

Global Medical Devices Manufacturer Selects Kneat to Digitize Validation

Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024

Kneat Announces Closing of $35.6 Million Bought Deal

Global Pharma Selects Kneat to Digitize Computer System Validation

Kneat Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus

Kneat Announces Record Revenue for Second Quarter 2024

Kneat Announces Results of Voting at Annual General Meeting

Newsletter